Novel therapies for Hodgkin Lymphoma.

about

Novel therapies for Hodgkin Lymphoma.

Item

http://www.wikidata.org/entity/Q36612532

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Novel therapies for Hodgkin Lymphoma.

@ast

Novel therapies for Hodgkin Lymphoma.

@en

type

Item

label

Novel therapies for Hodgkin Lymphoma.

@ast

Novel therapies for Hodgkin Lymphoma.

@en

prefLabel

Novel therapies for Hodgkin Lymphoma.

@ast

Novel therapies for Hodgkin Lymphoma.

@en

P1476

Novel therapies for Hodgkin Lymphoma.

@en

P2093

John W Sweetenham

http://www.w3.org/2001/XMLSchema#string

P2860

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206.

Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death

Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma.

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential.

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.

P304

23-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2040620710387980

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236106926

http://www.w3.org/2001/XMLSchema#string

P698

23556069

http://www.w3.org/2001/XMLSchema#string

P932

3573386

http://www.w3.org/2001/XMLSchema#string